BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
McKinsey
Argus Health
Novartis
Citi
US Department of Justice
Cantor Fitzgerald
Colorcon
Moodys

Generated: January 19, 2018

DrugPatentWatch Database Preview

CLAFORAN Drug Profile

« Back to Dashboard

Drug patent expirations by year for CLAFORAN
Medical Subject Heading (MeSH) Categories for CLAFORAN

US Patents and Regulatory Information for CLAFORAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 062659-001 Jan 13, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharm Holdings CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-002 May 20, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharm Holdings CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 050547-003 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharm Holdings CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-004 May 20, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 062659-002 Jan 13, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharm Holdings CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 050547-002 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharm Holdings CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 050547-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharm Holdings CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 050547-004 Dec 29, 1983 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharm Holdings CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-003 May 20, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharm Holdings CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-001 May 20, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Accenture
Chubb
Queensland Health
Cerilliant
McKinsey
Dow
Julphar
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot